康东伟
个人信息Personal Information
研究员 硕士生导师
性别:男
学历:博士研究生毕业
学位:医学博士学位
在职信息:在职
所在单位:药学院
入职时间:2020-10-22
学科:药物化学
联系方式:18663770120
扫描关注
- 暂无内容
- 黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicianal Chemistry, 64, 13604-13621, 2023.
- 黄伯世. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 28, 1348, 2023.
- 郑义. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 5, 2021.
- 刘新泳. Recent applications of click chemistry in drug discovery. Expert Opin Drug Discov, 2021.
- 刘新泳. Overview of Recent Strategic Advances in Medicinal Chemistry. J Med Chem, 2021.
- 刘新泳. Development of a practical synthesis of etravirine via a microwave-promoted amination. chemistry central Journal, 2021.
- 暂无内容
- 新型TAAR1-Gs/Gq双信号通路激动剂的发现、优化及其抗精神分裂症活性研究, 2024/08/23-2028/12/31
- (包干项目)慢性HBV感染导致肝脏免疫耐受和耗竭新机制, 2024/01/01-2026/12/01
- 新型高效抗耐药性核苷(酸)类SARS-CoV-2 聚 合酶抑制剂的设计、合成与活性评价, 2023/12/11-2026/12/31
- 病毒感染诱导巨噬细胞代谢重塑调控固有免疫反应 的机制解析与干预策略, 2023/12/01-2026/11/30
- 广谱抗耐药性抗冠状病毒药物研发, 2022/01/01-2024/12/31
- 基于靶标结构的新型HIV-1逆转录酶变构抑制剂的设计、合成与活性评价, 2022/09/07-2026/12/31
- 暂无内容